Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep-Oct;7(7):2415-2418.e3.
doi: 10.1016/j.jaip.2019.03.046. Epub 2019 Apr 5.

Vulnerability of pediatric patients with mitochondrial disease to vaccine-preventable diseases

Affiliations

Vulnerability of pediatric patients with mitochondrial disease to vaccine-preventable diseases

Shannon K Kruk et al. J Allergy Clin Immunol Pract. 2019 Sep-Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Immune symptoms in patients with MD.
Table of immune symptoms derived from primary immunodeficiency questionnaire and additional questions. See Table E2 for the question list.
Figure 2:
Figure 2:. Vaccination status in patients with MD.
A) Adherence to vaccination recommendations; B) Vaccine titers; C) Subgroup analysis of patients who were adherent to vaccination schedule; D) Serum IgG levels and titer status in vaccinated individuals. 0–2 titers (N = 12), ≥3 titers (N = 7), Student’s t-test *P < 0.05.

References

    1. Ng YS, Turnbull DM. Mitochondrial disease: genetics and management. J Neurol 2016; 263:179–91. - PMC - PubMed
    1. Kapnick SM, Pacheco SE, McGuire PJ. The emerging role of immune dysfunction in mitochondrial diseases as a paradigm for understanding immunometabolism. Metabolism 2018; 81:97–112. - PMC - PubMed
    1. Naviaux RK, Nyhan WL, Barshop BA, Poulton J, Markusic D, Karpinski NC, et al. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers’ syndrome. Ann Neurol 1999; 45:54–8. - PubMed
    1. Edmonds JL, Kirse DJ, Kearns D, Deutsch R, Spruijt L, Naviaux RK. The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection. Arch Otolaryngol Head Neck Surg 2002; 128:355–62. - PubMed
    1. Tarasenko TN, Pacheco SE, Koenig MK, Gomez-Rodriguez J, Kapnick SM, Diaz F, et al. Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation. Cell Metab 2017; 25:1254–68 e7. - PMC - PubMed

Publication types